Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours Β· Estimated delivery Oct 12 - Oct 17
Suppress the release of glucagon (a hormone that raises blood sugar)
It is a triple agonist, meaning it activates GLP-1 (glucagon-like peptide-1), GIP (glucose- dependent insulinotropic polypeptide) and glucagon receptors making it one of the most comprehensive peptide candidates in obesity, insulin resistance and metabolic research
What Causes GLP-1 Injection Site Reactions Understanding the reasons behind injection site reactions can help reduce their occurrence
The pathogenesis of Alzheimers disease: a reevaluation of the amyloid cascade hypothesis
When fullness happens faster, drinking between meals can help save stomach space for food
PLoS ONE 11 , e0158205 (2016)
US$ 22.25
US$ 29.18
US$ 28.86
US$ 29.60
US$ 28.88
